APPLICATION
ANDA079237
TYPE
ANDA
ORIGINAL APPROVAL
2009-04-02
LATEST ACTION
2024-02-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
HYDROCHLOROTHIAZIDEDiscontinued
HYDROCHLOROTHIAZIDE 12.5MG · CAPSULE · ORAL
Approval history
2024-02-01Labeling · Supplement 14 · standardAP
2011-08-17Labeling · Supplement 5AP
2009-04-02OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.